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ABSTRACT  Monoclonal  antibodies were generated against the intermediate filament  proteins 
of  different  human  cells.  The  reactivity  of  these  antibodies  with  the  different  classes of 
intermediate filament  proteins was determined  by indirect immunofluorescence  on cultured 
cells,  immunologic  identification on  SDS polyacrylamide  gels  ("western  blot"  experiments), 
and  immunoperoxidase assays on  intact tissues. The following four antibodies are described: 
(a)  an  antivimentin antibody generated  against  human  fibroblast cytoskeleton;  (b),  (c)  two 
antibodies that recognize a 54-kdalton  protein in human  hepatocellular  carcinoma  cells;  and 
(d)  an antikeratin antibody made  to stratum  corneum  that recognizes  proteins of molecular 
weight 66 kdaltons and 57 kdaltons. 
The  antivimentin  antibody reacts with vimentin  (58 kdaltons),  glial  fibrillary acidic protein 
(GFAP), and  keratins  from  stratum  corneum,  but does  not recognize  hepatoma  intermediate 
filaments.  In  immunofluorescence  assays, the  antibody  reacts with  mesenchymal  cells  and 
cultured  epithelial  cells  that express vimentin. This  antibody decorates  the  media  of  blood 
vessels in tissue sections. One antihepatoma filament antibody reacts only with the 54 kdalton 
protein of these cells and, in immunofluorescence  and immunoperoxidase assays, only recog- 
nizes epithelial cells. It reacts with almost all nonsquamous epithelium in intact tissue, but fails 
to  recognize  squamous  epithelium.  Thus  this  antibody  identifies  an  epithelial-specific 
"cytokeratin"  molecule  present  in  only  nonsquamous  epithelium.  The  other  antihepatoma 
filament  antibody  is  much  less selective,  reacting  with  vimentin,  GFAP, and  keratin  from 
stratum  corneum.  This  antibody decorates  intermediate filaments  of both  mesenchymal  and 
epithelial  cells.  The  antikeratin  antibody  recognizes  66-kdalton  and  57-kdalton  proteins  in 
extracts of stratum corneum and also identifies proteins of similar molecular weights in all cells 
tested.  However,  by  immunofluorescence,  this  antibody  decorates  only  the  intermediate 
filaments of epidermoid carcinoma cells. When assayed on tissue sections,  the antibody reacts 
with  squamous  epithelium  and  some,  but  not all,  nonsquamous  epithelium.  Therefore  this 
antistratum  corneum  antibody  and  the  anti-54-kdalton  antibody  identify  unique  epitopes 
present  in  the  various  cytokeratin  molecules  of  epithelial  ceils.  None  of  the  hybridoma 
antibodies react with neurofilament proteins. 
The different patterns of reactivity of these antibodies suggest that many of the immunolog- 
ically distinct intermediate filament proteins contain common  antigenic determinants. 
Intermediate  filaments,  distinctive  cytoskeletal  components 
present in virtually all mammalian cells, are distinguished from 
other cytoskeletal structures such as microtubules and micro- 
filaments on the basis of filament diameter and protein com- 
position. A unique feature of intermediate filaments is that the 
filaments  of different  cells  are  immunochemically  distinct. 
They have been divided into five subclasses based upon bio- 
chemical analyses  and  reactivity with  a  series of polyclonal 
414 
rabbit  or  guinea  pig antisera  (1).  The  following classes of 
intermediate filaments have been defined: (a) fibroblast inter- 
mediate filaments (FIF; vimentin, decamin), present in a wide 
range of mesenchymal cells in vivo, but present as well in some 
epithelial cell lines in vitro (24). This protein is composed of 
a single subunit with a molecular weight in the range of 52-58 
kdaltons. (b) Keratin (prekeratin, cytokeratin), a complex series 
of proteins  with  molecular weights  ranging  from  40  to  70 
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(5-8). (c) Desmin, a  52-kdalton protein characteristic of cells 
of muscle origin, e.g.,  skeletal muscle, where it is localized to 
the Z-disk.  It is also present  in BHK cells (9,  10). (d) Glial 
fibrillary  acidic  protein  (GFAP),  the  protein  component  of 
intermediate  filaments of astrocytes, with a molecular weight 
of approximately 51 kdaltons (11-14). This molecule is appar- 
ently specific to cells of the central nervous system, although 
its presence in the peripheral nervous system has been reported 
(15). (e) Neurofilaments, intermediate filaments of neurons of 
the central and peripheral nervous system, composed of three 
proteins  with  molecular weights 210 kdaltons,  160 kdaltons, 
and 70 kdaltons (16). The relationship of these proteins to one 
another is not clear. 
Polyclonal  antisera  made  against  a  purified  intermediate 
filament protein have been extremely useful in distinguishing 
among  the  different  molecules.  However,  monoclonal  anti- 
bodies afford a much higher degree of specificity than can be 
obtained with polyclonal sera because they recognize a single 
unique three-dimensional structure or sequence (epitope). Be- 
cause the different intermediate  filament proteins apparently 
contain similar as well as unique sequences (17,  18), it should 
be possible to isolate hybridoma antibodies specific for a single 
intermediate  filament  protein,  and  others  able  to  recognize 
more than one type of intermediate  fdament protein (19).  A 
panel of hybridoma antibodies made against each of the fila- 
ment proteins would therefore be useful in identifying unique 
and  common sequences  in these  molecules.  In addition,  the 
antibodies  specific  for  a  single  molecule  could  be  used  to 
identify the cellular origin of different neoplasms (7,  20,  21) 
and  therefore  would  be  clinically  useful  in  the  practice  of 
pathology. 
We  report  here  the  characterization  of monoclonal  anti- 
bodies generated against vimentin (decamin), cytokeratin from 
a human hepatoma cell line, and keratin from human stratum 
corneum. These antibodies exhibit unique reactivities with the 
different classes of intermediate filament proteins. 
MATERIALS AND  METHODS 
Cells and Media 
The following human cell strains and cell lines were obtained from Dr. Helene 
Smith, Peralta Institute, Oakland, CA: Hs-0074 Int, normal intestine; Hs-0767 
BI,  normal bladder; Hs-0700T, metastatic adenocarcinoma; Hs-0766T, meta- 
static pancreatic carcinoma; Hs-0746T, metastatic gastric carcinoma; Hs-0696T, 
metastatic adenocarcinoma; Hs-0578T, carcinosarcoma of breast. Human hepa- 
tocellular carcinoma cell lines Hep3B and HepG2 were obtained from Drs. David 
Aden and Barbara Knowles, Wistar Institute, Philadelphia, PA. Human fibre- 
blasts were explanted  from foreskins.  Rhabdo-I  was derived  from a  human 
rhabdomyosarcoma. 
All cells, with the exception of Hs-0074 Int, were grown in DME supplemented 
with  penicillin  (100  U/ml)  and streptomycin (100 /~g/ml).  Hs-0074 Int  was 
maintained in  Eagle's minimal essential medium (MEM)  supplemented with 
similar antibiotics. Newborn calf  serum (I 0% vol/vol, Gibco Laboratories, Grand 
Island Biological Co., Grand Island, NY) was used for all cells except Hep3B, 
and HepG2, which received 5% newborn caff serum, 5% fetal calf serum. All of 
the lines from Dr.  Smith also received 2  /~g/ml insulin (Calbiochem-Behring 
Corp., American Hoechst Corp., San Diego, CA). 
Preparation  of Intermediate Filament Proteins 
Cells were grown to semi-confluence in  100-mm dishes and extracted with 
Triton-high salt according to Franke et aL (22). Cell monolayers were washed 
two times with TNM buffer (10 mM Tris, 140 mM NaC1, 5 mM MgCI2, pH 7.6) 
and  incubated  with  1%  Triton  X-100  in  TNM  buffer  for  1  rain  at  room 
temperature. The monolayers were washed twice with TNM buffer and exposed 
to 0.5% Triton X-100, 1.5 MKC1 for 30 rain at room temperature, after which the 
ceils  were  washed  twice  in  TNM  and  scraped  off the  dish  with  a  rubber 
policeman. The insoluble material was suspended in TNM  and centrifuged at 
10,000 rpm for 20 min at 4°C  in  a  Sorvall centrifuge (Dupont  Instruments- 
SorvaU Biomedical Div., Dupont Co., Newtown, CT). The pellet was resuspended 
in  1% SDS, 50 mM Tris, pH 6.8, and stored at -20°C. The human fibroblast 
cytoskeletons remained attached to the dish during Triton-high salt extraction. 
All other cells extracted in this manner detached from the dish during the Triton- 
high salt incubation. When this occurred, the cell cytoskeletons were centrifuged 
at 10,000 rpm for 20 min at 4°C and washed with TNM by successive cantrifu- 
gations. 
Keratin was extracted from human stratum corneum from the sole of the foot 
by the  method of Sun and Green (23).  Fragments of stratum corneum were 
extracted overnight at 37°C in 5% SDS, 1% fl-mercaptoethanol at a concentration 
of 4 mg/mL The extracted tissue was centrifuged to remove the insoluble material 
and stored at -20°C. 
Production of Hybridomas 
Hybridoma antibodies to intermediate filament proteins were generated ac- 
cording to the basic outline of Krhler and Milstein (24) as modified by Nowinski 
et al. (25). Preparations of intermediate filaments as described above from ~ l07 
cells were solubilized in  1% SDS and injected intraperitoneally into a  5-wk-old 
BALB/c mouse; injections were repeated at 2  and 4  wk.  10  100-mm plates of 
semiconfluent cells  were extracted for each injection.  For the  production of 
antikeratin antibodies, -200/tg of solubilized keratin was used for each immu- 
nization. 3 d following the third injection, the mouse was sacrificed by overanes- 
thesia with ether. Spleen cells were fractionated into a single cell suspension by 
vigorous mincing and  passage through  fine  wire  mesh  and  fused  to  mouse 
myeloma cells (NS-1) at a ratio of 4:1 (spleen cells:myeloma cells) with polyeth- 
ylene glycol (PEG). Hybrid clones were grown in RPMI-1640 (Gibco Labora- 
tories) medium supplemented with  15% fetal calf serum, L-glutamine (1  mM), 
sodium pyruvate (1 mM), penicillin (100 U/ml), streptomycin (100/tg/ml; Gibco 
Laboratories),  and  0.1  mM  hypoxanthine,  0.40  #M  aminopterin,  0.16  mM 
thymidine (HAT; Sigma Chemical Co., St. Louis, Me). Cultures were maintained 
at 7% CO2 concentration at 37°C. Cells were fed with RPMI/HAT at days 4 and 
8; RPMI/HT at day 12; and RPMI-1640 every 4 d subsequent. 
Clones were generally visible 5-10 d after the fusion, and supernatants tested 
when the wells were between one-third and one-half confluent, generally 2-3 wk 
following the fusion. 
Screening of Hybridoma Antibodies 
Clones producing antibodies to cytoskeletal preparations were identified by 
assaying hybridoma supernatant fluids for binding to  formalin-, acetone-, or 
ethanol-fixed monolayers of cells by autoradiography or immune  fluorescence 
techniques. For autoradiography, human fibroblasts or Hep3B cells were grown 
to confluence in  96-well microtiter plates, washed two times with  1% bovine 
serum albumin (BSA; Sigma Chemical Co.) in PBS, and fixed for 10 min at 4°C 
with 3.7% formaldehyde in PBS. The fixed ceils were washed four times in  1% 
BSA ill PBS. 
50/d of supernatant were withdrawn from each hybridoma-containing well 
with a multichannel variable pipette (Finnipette, Labsyskms Oy, Helsinki, Fin- 
land) and added to the formalin-fixed ceils. Plates were incubated for 45 min at 
37°C and washed three times with  1% BSA in PBS. 50/xl of immunoglobulin 
fraction of rabbit antisera to mouse IgG (Miles Laboratories, Elkhart, IN) diluted 
1:400 in PBS were then added to all wells. Following incubation at 37°C for 45 
rain and three serial washes with 1% BSA in PBS, 50/d of staphylococcal protein 
A  (Sigma Chemical Co.), labeled via the lactoperoxidase method to a  specific 
activity of 5.51 #Ci/~tg, was added to each well at a  dilution of 105 cpm/50 ~tl. 
Following a 45-min incubation at 37°C and three serial washes with 1% BSA in 
PBS, positive wells were identified either by direct visualization following over- 
night autoradiography of the plates on Kodak XR-5 x-ray fill  backed by a 
Dupont Lightning Plus intensifying screen at -70°C, or by punching out indi- 
vidual well bottoms with a hammer and 6-ram diameter steel rod and counting 
directly in a gamma counter. In the latter method, positive wells were defined as 
those displaying counts three standard deviations or greater beyond the mean 
background (wells incubated initially with NS-I  supernatant or PBS). Positive 
wells identified by this initial screening were then tested by immunofluoresence 
to identify antibodies to intermediate filaments (see below). 
Antikeratin  antibodies were  assayed by  binding  to  keratin-coated dishes. 
Solubilized keratin (500 ng per well) was dried overnight on microtiter plates and 
the wells were washed with 1% BSA in PBS. 50 ,at of hybridoma supernatant was 
added to each well and processed as described above. 
Wells that were positive in the initial screening assay and by immunofluores- 
cence were cloned in a two-step procedure described elsewhere (25). In the first 
"miniclone" step, 3-5 cells/well were seeded into one or two 96-well plates with 
a  feeder layer of 106 thymocytes/well from  10-d-old BALB/c mice. The best 
growing cells,  which also produced strongly reactive supernatants, were then 
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cells were transferred 1o flasks, allowed to grow to high density, and  l07 cells 
were injected intraperitoneally into pristane-primed BALB/c mice. 10 d to 2 wk 
later, ascites fluid (5-10 ml/mouse) was withdrawn. Cell lines producing positive 
supematants were frozen and stored at -70°C in 10% DMSO. 
Im m unofluorescence 
Ceils were plated in growth medium on Teflon-coated slides containing 12 
wells (Meloy Laboratories, Springfield, VA) and allowed to attach overnight. The 
slides were washed in PBS,  fixed in 95% ethanol or acetone (-20°C for 10 min) 
and air dried. 25 pl of diluted superaatant from bybridoma culture medium or 
ascites fluid were added to each well and the slides incubated at 37°C for 45 min 
in a  humidified chamber. The slides were then washed in PBS and incubated 
with 25 #1 of FITC-conjugated goat anti-mouse IgG and IgM (1:40 dilution, Tago 
Inc., Burlmgame, CA) for 45 min at 37°C. The slides were washed with PBS, 
then water, and covershps were mounted with Aqua-Mount (Lemer Laboratories, 
New Haven, CT). Fluorescence was observed with a Zeiss fluorescence micro- 
scope with appropriate fluorescein excitation and emission filters. Fixation with 
cold 95% ethanol (-20°C) resulted in the best immunofluorescence pattern for 
the antivlmentin antibodies, whereas acetone fixation was better for the anti- 
hepatoma and antikeratin antibodies. 
SDS Polyacrylamide Gel Electrophoresis 
Slab gel electrophoresis was done according to Laemmli (26).  8% gels were 
used to analyze whole cell lysates or Triton-high salt-insoluble material. Whole 
cell lysates were prepared by washing confluent 100-ram plates with TNM buffer 
and solubilizing  the ceils with 1 ml of SDS sample buffer. Protein concentration 
of whole cell lysates was -0.4 mg/ml. Triton-high salt-insoluble material was 
dissolved in SDS sample buffer at a concentration of ~0.5 mg/ml. Samples were 
run with dithiothreitol (7.7  mg/ml). The absence of dithiothreitol in the SDS 
sample buffer did not affect the migration of the intermediate filament proteins 
in an 8% gel. 
Electropho-retic  Transfer of Proteins from 
Polyacrylamide Gels to Nitrocellulose Paper 
To identify the antigen recognized by the hybridoma antibodies, proteins 
separated on 8% SDS polyacrylamide gels were electrophoresed onto nitroceLlu- 
lose paper and incubated with test antibodies. The procedure was done according 
to Burnette (27) using a transfer apparatus similar to that described by Towbin 
et al. (28). Material tested included SDS lysates of whole ceils or the intermediate 
filament preparations made by Triton-high salt extraction of various cell lines. 
Pyronine Y (0.05%) was included in the SDS sample buffer to mark the bottom 
of the gel on the nitrocellulose paper. The SDS polyacrylamide gel was apposed 
to a  sheet of nitrocellulose paper,  and transfer was done overnight in 25 mM 
potassium phosphate, pH 6.5, at 100 mamp. The voltage gradient was -6 V/cm. 
Transferred proteins were identified on nitrocellulose by staining with amido 
black (0.1% in45% methanol/10% acetic acid) for 3 rain and destaining with 90% 
methanol/2% acetic acid. 
Immunologic Detection of Proteins on 
Nitrocellulose Paper 
All procedures were performed at room temperature. Nitrocellulose paper 
containing the transferred proteins was incubated in 25 ml of 5% bovine serum 
albumin (BSA) in 10 mM Tris, 0.9% saline, pH 7.4 (TSB buffer), for 90 min with 
gentle rocking. The antibody-containing aseites fluid was added directly to the 
BSA solution and incubated for another 90 min. The antibody was removed and 
the nitroceUulose washed according to the following regimen: (a) 50 ml of TSB, 
10 min; (b) 50 mt of 0.05% Triton X-100 in TSB, 20 min; (c) 50 ml of @05% 
Triton X-100 in TSB, 20 min; and (d) 50 ml of TSB, 10 min. The nitrocellulose 
paper was then incubated with 5% BSA containing 5 x  105 cpm of 1251-goat anti- 
mouse IgG, (IgG and lgM specific [Tago Inc.]).  After 60 min, the nitrocellulose 
paper was washed as  above,  dried,  and  exposed to  Kodak  XR-5  film with 
Dupont Lightning Plus enhancing filters. Exposure times varied from 6 to 18 h. 
Aseites fluid dilutions of 1:200-1:1,000  were routinely used, but ascites fluids 
were active to a dilution of 1:10,000. 
GFAP and Neurofilament Protein Preparations 
GFAP and neurofilament proteins prepared from rat spinal cord were ob- 
tained from Dr. F. C. Chin, Department of Neurology, Albert Einstein College 
of Medicine (29). Anti-GFAP sera was a gift from Dr. James Goldman, Depart- 
ment of Neurology, Albert Einstein College of Medicine. 
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Two-Dimensional Peptide Analysis 
Peptide maps were prepared exactly as described by Sage et al. (30). Individual 
protein bands were cut from gels, iodinated with Bolion-Hunter reagent (250 ~tCi 
per incubation, New England Nuclear, Boston, MA), and digested with proteinase 
K  (40  /~g/ml,  E.M.  Biochemicals,  Darmstadt,  Germany)  for  18  h  at  37°C. 
Iodinated peptides (2 x  105 cpm) were spotted onto cellulose acetate plates (10 
x  10 cm) and separated by electrophoresis in one dimension and chromatography 
in the second dimension. The dried plates were exposed to Kodak (BB-5) film 
with Dupont Lightning Plus enhancing filters for 2~5 h. 
Immunocytochemistry 
Autopsy-derived samples of human pancreas and skin were obtained from the 
University Hospital of the University of Washington. They were fLxed in Carnoy's 
fixative (60% ethanol, 30% chloroform, 10% acetic acid) for 3 h and embedded in 
paraffin. 7-/an sections were deparaffmized and endogenous peroxidase activity 
was blocked with 0.01% H202 in methanol (30 min). Monoclonal antibodies were 
applied to slides in dilutions ranging from 1:1000 to 1:8000 (30 min). Following 
a PBS wash, they were then incubated with biotinylated-anti-mouse IgG (Vector 
Laboratories, Burlmgame, CA) at a dilution of 1:500 (30 min). Again, following 
a  PBS wash, a solution of avidin-biotinylated horseradish peroxidase complex 
(Vector Laboratories, Burlmgame, CA) was then applied (30 min), followed by 
an additional PBS wash. Peroxidase activity was identified by incubating with a 
solution of 0.1% 3,Y-diaminobenzidine (DAB) and @03% hydrogen peroxide in 
0.05  M Tris buffer, pH 7.6. Sections were counterstained with methyl green. 
RESULTS 
Sources of Antigen from Different Tissues 
Cytoskeletal preparations from a variety of human cells were 
examined to identify sources of different intermediate filament 
proteins.  Fibroblasts,  a human hepatocellular  carcinoma line 
(Hep3B),  and  stratum  corneum  were  chosen.  An  8%  SDS 
polyacrylamide gel of Triton-high salt-insoluble material from 
these cells is shown in Fig. 1. Vimentin (decamin), a 58-kdalton 
protein,  is present  in human fibroblast  cytoskeletal  prepara- 
tions (lane a). Hep3B, the hepatoma line, contains a prominent 
band at 54 kdaltons and a faint band at 58 kdaltons (land b). 
Additional minor bands are present in the 66-70-kdalton  re- 
gion.  A43 l,  a  human epidermoid carcinoma line,  contains a 
54-kdalton band, a 56-kdalton band, and minor bands in the 
66-70-kdalton region and at 59 kdaltons and 49 kdaltons (lane 
c).  Lanes a, b, and c also exhibit bands of 44 kdaltons which 
contain actin.  Keratin,  solubilized  from stratum corneum,  is 
predominantly composed of a doublet of 66 kdaltons and single 
bands at 57 kdaltons,  51  kdaltons, and 49 kdaltons (lane d). 
There is a smear of minor bands in the 66-70-kdalton  region 
and other minor bands scattered throughout the 40-66-kdalton 
region. Monoclonal antibodies were made to vimentin (lane a), 
cytoskeleton from Hep3B  (lane b),  and keratin from stratum 
corneum (lane d). Table I lists the different antibodies to be 
discussed and the immunogens against which they are directed. 
Fig.  1 also shows preparations containing the neurofdament 
proteins and GFAP isolated from rat brain (supplied by Dr. F. 
C. Chin, Department of Neurology, Albert Einstein College of 
Medicine). Neurofflaments are composed of peptides of molec- 
ular weight 200 kdahons,  160 kdaltons and 70 kdaltons (lanes 
e and j0. GFAP (52 kdaltons) is also present in the neurof'da- 
ment preparation (lane e). The high molecular weight neuro- 
filament protein usually migrates at 210 kdaltons.  The lower 
molecular  weight  in  our  preparation  probably  results  from 
partial degradation of the molecule. 
Immunofluorescence Studies on Cell Unes and 
Immunological Identification of Antigens 
Four monoclonal antibodies were isolated and characterized 
(Table  I).  Immunofluorescence  assays  were  performed  on  a FIGURE 1  SDS polyacrylamide  gel (8%) of cytoskeletal 
preparations from different sources. ~t0-20/tg of pro- 
tein was added in each well. (a) Fibroblasts; (b) Hep3B 
(hepatocellular  carcinoma); (c) A431 (epidermoid car- 
cinoma); (d)  keratin  from stratum  corneum; (e)  rat 
neurofilament proteins; (f)  rat 200-kdalton  neurofila- 
ment protein;  (g)  molecular weight markers of 200 
kdaltons,  116 kdaltons, 94 kdaltons,  68 kdaltons,  and 
43 kdaltons. 
TABLE  I 
Hybridoma  Antibodies to Intermediate  Filament  Proteins 
Antibody Name  Antibody generated against 
17flg3  Cytoskeleton  from fibroblasts 
35flHll ~,  Cytoskeleton  from Hep3B 
35flD12J 
34fl[12  Keratin from stratum  corneum 
variety of cultured human ceils  (both normal and neoplastic) 
fixed in either -20°C ethanol or -20°C acetone.  Results are 
shown in Fig. 2 and summarized in Table II. 
The technique of "western blotting" was used to identify the 
antigen(s) recognized by each of these antibodies (27). In these 
experiments, SDS lysates of whole cells were used (Fig. 3, lanes 
a-J),  but  identical  results  were  obtained  using  the  insoluble 
residue from Triton-high salt-extracted ceils (data not shown). 
The reactivity of the antibodies with purified neurofflaments 
(Fig. 3, lanes g and h), GFAP (Fig. 3, lane g) and keratin from 
stratum corneum (Fig. 3, lane i) was also examined. 
17fiG3:  Antibody 17BG3,  generated against fibroblast cy- 
toskeleton, reacts with human fibroblasts but not with Hep3B 
(Fig. 2a and  2b).  In immunoblot experiments,  the antibody 
recognizes vimentin (58 kdaltons) in fibroblasts and Hs-0578T, 
a  breast carcinosarcoma (Fig. 3 A, lanes a  and b). All of the 
cells  in Table II that react with  17fiG3 contain vimentin (58 
kdaltons), even those of epithelial origin (bladder,  fetal intes- 
tine, and two adenocarcinomas). These results are in agreement 
with  Franke et al.  (2),  who found that many epithelial  cells 
that normally lack vimentin in vivo contain this protein when 
cultured in vitro. 
Four cell lines,  Hep3B, HepG2, A431, and Hs-0700T, fail to 
react with 17fiG3 by fluorescence assays (Table II) and do not 
contain  any  immunologically  detectable  vimentin  (Fig.  3A, 
lanes c-f). Hep3B contains a minor band at 58 kdaltons (Fig. 
1, lane b) but this molecule is not recognized by 17fiG3.  Two- 
dimensional peptide analyses demonstrate that vimentin from 
human fibroblasts and the 58-kdalton protein from Hep3B are 
markedly different (see below). 
In  some  assays,  varying  reactivity  with  a  protein  at  44 
kdaltons is  seen in cells  that either possess or lack vimentin. 
For example,  a  44-kdalton band is recognized by  17fig3  in 
A431 (Fig. 3 A, lane e). This reactivity varies from cell line to 
cell line and from assay to assay. We do not as yet understand 
this variable reactivity. 
The antivimentin antibody cross reacts with GFAP and the 
high molecular weight bands of keratin (66 kdaltons, 57 kdal- 
tons)  (Fig.  3  A),  but  does  not  recognize  the  neurofdament 
peptides.  The  recognition  of GFAP,  although  weak  on this 
autoradiogram,  is  stronger  in  others  (data  not  shown).  In 
addition,  we  cannot  dilute  the  antibody  so  that  it  retains 
reactivity with  vimentin,  but no longer recognizes GFAP or 
keratin. When approximately equal amounts of vimentin, ker- 
atin,  and GFAP are loaded on a  gel,  recognition of each of 
these proteins at different antibody dilutions is identical (data 
not shown). 
It is possible that the 52-kdalton band in the neurofilament 
preparation is not GFAP but, instead, a proteolytic breakdown 
product of vimentin (31).  This possibility is unlikely because 
polyclonal anti-GFAP sera (supplied by Dr. James Goldman, 
Albert Einstein College of  Medicine) reacts with the 52-kdalton 
band but does not recognize vimentin (data not shown). 
35fill l l:  Hybridoma 35drill,  made against Hep3B inter- 
mediate  fdaments,  decorates  filaments  of Hep3B  but  not  of 
flbroblasts (Fig. 2 c and 2 d).  The antibody recognizes a  54- 
kdalton peptide  in Hep3B, HepG2, A431, and Hs-0700T, all 
epithelial cell neoplasms (Fig. 3 B). Hs-0696T and Hs-0746T, 
both of which are positive by fluorescence, also contain the 54- 
kdalton protein (data not shown). No peptides are identified in 
fibroblasts  or Hs-0578T,  nor in the epithelial  ceils  (bladder, 
fetal intestine) listed in Table II that are negative in immuno- 
fluorescence assays (data not shown). This antibody reacts with 
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1:100 and fluorescein-conjugated  goat anti-mouse IgG +  IgM diluted 1:40.  (a) Antivimen- 
tin, 17flG3, on fibroblasts; (b)  antivimentin, 17flG3, on Hep3B (hepatocellular carcinoma); 
(c)  antihepatoma filament,  35flHll  on  Hep3B;  (d)  antihepatoma filament,  35flHll,  on 
fibroblasts;  (e)  antihepatoma  filament  35flD12  on  Hep3B;  (f)  antihepatoma  filament 
35flD12 on fibroblasts;  (g)  antikeratin 34flE12 on A431  (epidermoid carcinoma),  x  400. 
TABL~  II 
Immunofluorescence with Monoclonal Antibodies 
17flG3  (vimen-  35flHll  (hepa- 
tin, 58 kdal-  toma IF, 54  35flD12  (hepa-  34flE12  (stra- 
Cell line  Origin  tons)  kdaltons)  tome IF)  turn corneum) 
Fibroblasts  Foreskin  +  -  +  - 
Hs0767  Normal  bladder  +  -  +  - 
Hs0074  Normal fetal intestine  +  -  +  - 
HsO578T  Carcinosarcoma of breast  +  -  +  - 
Rhabdo-1  Rhabdomyosarcoma  +  -  +  - 
Hep38  Hepatocellular carcinoma  -  +  +  - 
HepG2  Hepatocellular carcinoma  -  +  +  - 
Hs0700T  Adenocarcinoma, metastatic to pelvis  -  +  +  +_ 
A431  Epidermoid carcinoma, vulva  -  +  +  + 
Hs0696T  Adenocarcinoma,  metastatic to bone  +  +  +  - 
Hs0746T  Adenocarcinoma,  metastatic to muscle  +  +  +  - 
Ascites fluids were tested  by immunofluorescence at dilutions of 1:100. The filaments 
against which the antibodies  were generated. 
no other intermediate filament proteins (Fig. 3 B). It is there- 
fore  highly  specific,  recognizing  only  a  54-kdalton  protein 
present in many cells of epithelial origin. 
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listed  in parentheses under the antibody number show the immunogen 
35flD12:  Antibody 35flD12, isolated from the same fusion 
as  35flHll,  recognizes  the  intermediate  filaments  of  both 
Hep3B and fibroblasts (Fig. 2  e and 2 f)  and reacts with all FIGURE  3  Nitrocellulose blotting of different cells with hybridoma antibodies. Cells were lysed in SDS sample buffer, electropho- 
resed  on  an 8%  SDS  polyacrylamide gel,  and  electrophoretically transferred  to  nitrocellulose  paper.  Nitrocellulose  strips  were 
incubated with the different hybridoma ascites fluids. The different cells tested are listed in Table II. Lane a, fibroblasts; lane b, Hs- 
0578T;  lane c, Hep3B; lane d, HepG2; lane e, A431; lane f, Hs-0700T; lane g, rat neurofilament preparation; lane h, rat 200 kdalton 
neurofilament protein; lane i, keratin from stratum corneum. ~10-20 p.g of protein was added per well. (A)  Antivimentin, 17flG3, 
1:200  dilution;  (B)  Antihepatoma  filament  35flHll,  1:500  dilution;  (C)  Antihepatoma  filament  35flD12,  1:200  dilution;  (D) 
Antikeratin, 34flE12,  1:200 dilution. The large irregular spot in 3  C, lane  c, is an artifact. 
cells  tested  (Table  II).  In immunoblot experiments,  it  reacts 
with several types of intermediate filament proteins (Fig. 3 c). 
It binds to vimentin (58  kdaltons) in fibroblasts (lane a),  the 
54-kdalton and  56-kdalton proteins  of A431  (lane  e),  GFAP 
(lane g), and all the major keratin bands (lane i). It does not, 
however, recognize the different neurofilament proteins (lanes 
g and h).  The antibody also recognizes a  44-kdalton and 40- 
kdalton molecule in HepG2, and 44-kdalton proteins in A431 
and  Hs-0700T.  The  reactivity  with  these  lower  molecular 
weight bands is highly variable, similar to the variable reactiv- 
ity of 17fiG3  with the 44-kdalton protein of A431. This anti- 
body  therefore  appears  to  recognize  a  common  epitope  in 
many different intermediate filament proteins. 
The antibody does not recognize the 54-kdalton proteins of 
the hepatoma lines or Hs-0700T even though these  lines are 
positive  in  immunofluorescence assays.  One  explanation  for 
this  observation  is  that  the  antibody  cannot  recognize  the 
epitope in the SDS denatured protein from these cells, but can 
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that  the  54-kdalton  proteins  of these  different  cells  are  not 
identical; two-dimensional peptide maps show that these pep- 
tides are indeed different (see below). 
34fl~t2:  Hybridoma  34flE12,  generated  against  keratin 
from stratum corneum, is only positive by immunofluorescence 
on A431, the epidermoid carcinoma (Fig. 2 g). It is negative on 
fibroblasts, Hep3B, and all other cells (Table II). This antibody 
binds  to the  66-kdalton  and  57-kdalton proteins  in  stratum 
corneum and reacts less strongly with the 51-kdalton and 49- 
kdalton molecules (Fig. 3 D, lane i). Interestingly, the antibody 
identifies proteins of 66 kdaltous and 57 kdaltons in all cells 
tested,  even  those  negative  in  immunofluorescence  assays. 
These peptides are very minor components of the Triton-high 
salt-insoluble  material  from cells.  Thus,  although specific in 
immunofluorescence assays on tissue culture cells and immu- 
noperoxidase tests  on intact tissue  (see below),  the antibody 
recognizes  similar  molecular  weight  peptides  in  all  cells  in 
immunoblot experiments. 
The immunoautoradiograph of the antikeratin antibody al- 
ways has this "smeared" appearance, which may be related to 
the  degree  of reduction  of the proteins.  If the  gels are  run 
without reducing agent, the antibody does not recognize any 
bands on the nitrocellulose paper either in the position of the 
keratin  bands  or  elsewhere  (data  not  shown).  The  keratin 
preparation used as immunogen was reduced with fl-mercap- 
toethanol, so we believe the antibody may recognize only the 
reduced  protein.  Increasing  the  amount  of reducing  agent 
causes the 57-kdalton band to decrease in intensity, but does 
not  affect  the  66-kdalton  peptide  (data  not  shown).  This 
hybridoma recognizes none of the other intermediate filament 
proteins in fibroblasts, hepatoma cells, or neural tissue. 
Two-Dimensional Peptide Maps 
The immunofluorescence and  "western  blot" results  raise 
questions about similarities and differences among the different 
intermediate filament proteins. We performed two-dimensional 
peptide analyses to answer the following three questions: (a) 
are vimentin and the 58-kdalton protein in Hep3B related? (b) 
Are the 54-kdalton peptides of Hep3B and A431 identical? and 
(c) Does the 66-kdalton protein from stratum corneum resem- 
ble the 66-kdalton molecules from Hep3B and A431? 
VIMENTIN  VS.  THE  58-KDALTON  PROTEIN  FROM 
rIEP3a:  The peptide  maps of vimentin  and  the  58-kdalton 
protein  from Hep3B  are  quite  different  (Fig.  4  a  and  4  b). 
Additionally, the maps of the 54-kdalton proteins from Hep3B 
(Fig. 4 c) and A431 (Fig. 4 d) differ from that of vimentin, as 
does the map of the 44-kdalton band from A431  (Fig. 4  e). 
Thus, vimentin and these other proteins are clearly different. 
54-KDALTON  PROTEINS  OF  HEP3B  AND  A43 l: 
"Western  blot"  experiments  demonstrate  that  antibody 
35flD12 recognizes the 54-kdalton protein from A431 but not 
Hep3B. The peptide  maps show both similarities  and differ- 
ences in the peptides (Fig. 4 c and d). The more hydrophobic, 
less-charged spots are almost identical,  but the more-charged 
peptides show many differences. We conclude that the varia- 
tion in reactivity with  35flD12  results  from structural  or se- 
quence differences in the two molecules. 
66  KDALTONS  FROM  STRATUM  CORNEUM  VS.  66 
KDALTONS  FROM  HEP3B  AND  A431:  Antibody  34flE12 
recognizes a 66-kdalton band in preparations of stratum cor- 
neum and  a  protein  of similar  molecular weight in all cells 
tested.  The 66-kdalton protein from stratum corneum (Fig. 4 
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J0 differs from the 66-kdalton molecules of Hep3B (Fig. 4 g) 
and  A  431  (Fig.  4  h),  whereas  these  latter  two proteins  are 
practically identical. The cell-derived 66-kdalton proteins prob- 
ably share a common epitope(s) with the molecule from stratum 
corneum. 
The reason for the difference in immunofluorescence stain- 
hag  by  34flE12  on  A431  and  Hep3B  remains  unclear.  The 
peptide maps of the 66-kdalton molecules from these two cells 
are identical, yet antibody 34flE12 decorates the intermediate 
filaments  of only  A431.  Possible  explanations  include  very 
subtle sequence differences in the molecules, different intercel- 
lular localizations of the proteins in the two cells, or a difference 
in the way the molecules associate with the intermediate fila- 
ments. For example, in Hep3B the 66-kdalton protein may be 
surrounded by other proteins such that the antibody does not 
have access to the epitope. 
Reactivity with Intact Tissues 
To further characterize these antibodies, we examined their 
ability to react with tissue obtained from autopsy and surgical 
specimens.  Samples of skin and pancreas were fixed in Car- 
noy's solution, and reactivity was demonstrated by immuno- 
peroxidase techniques. A more detailed analysis of reactivity is 
in preparation. 
35fl H l 1"  The antihepatoma intermediate filament antibody 
reacts with pancreatic acinar and duct cells (Fig. 5 c) and sweat 
gland epithelia (data not shown). It fails to recognize epidermis 
and mesenchymal tissue such as blood vessels and dermis (Fig. 
5  a).  The  absence  of decoration  of squamous  epithelia  is 
consistent  with  the  inability  of this  antibody  to  recognize 
keratin from stratum corneum and suggests that the 54-kdalton 
protein recognized by this antibody is specific for nonsquamous 
epithelium.  In  addition,  the  antibody  does  not  react  with 
skeletal muscle or nervous tissue (data not shown). 
34fie 12:  The antikeratin antibody is specific for epidermis 
and some but not all nonsquamous epithelium. The full thick- 
ness of the epidermis is heavily stained with this antibody (Fig. 
5 b), as is the epithelium of the sweat glands (data not shown). 
In the pancreas, the duct ceils are positive, but the acinar cells 
are negative (Fig.  5  d).  Mesenchymal tissues  such as  blood 
vessel,  smooth muscle, skeletal muscle, and dermis, as well as 
nervous tissue, fail to react with this antibody (data not shown). 
Thus  this  antibody reacts  with  squamous  epithelium  and  a 
subset of nonsquamous epithelium. 
17fiG3:  This antibody most strongly reacts with the media 
of  blood vessels (Fig. 5 e) and also manifests a weaker reactivity 
with  dermal  fibrous  tissue  (data  not  shown).  The  antibody 
reacts with none of the epithelial cells in these sections, includ- 
ing epidermis,  sweat  gland,  pancreatic  acinar  cells,  or pan- 
creatic  duct  cells  (data  not  shown).  Thus,  this  antibody  is 
specific for mesenchymal tissue. 
DISCUSSION 
Common and Unique Epitopes in Intermediate 
Filament Proteins 
Monoelonal  antibodies  to  different  intermediate  filament 
proteins  have  been  isolated  and  the  antigens  recognized  by 
these  antibodies  identified.  The  reactivity  of the  antibodies 
with different intermediate filament proteins is summarized in 
Table  III.  Antibody  35flHll  recognizes  only  a  54-kdalton 
protein found in epithelial cells,  whereas hybridoma 34flE12 FIGURE  4  Two-dimensional peptide maps of intermediate filament proteins. ~2 x  105 cpm of ~2~l-labeled  peptides were applied 
to cellulose acetate plates. Electrophoresis is from  left to right.  Chromatography runs from  bottom to top.  (a)  58  Fib, fibroblast 
vimentin, 58 kdaltons; (b)  Hep3B, 58 kdaltons (c) Hep3B , 54 kdaltons; (d) A431, 54 kdaltons; (e) A431, 44 kdaltons; (f) keratin, 
stratum corneum, 66 kdaltons; { g) Hep3B, 66 kdaltons; (h) A431, 66 kdaltons. FIGURE S  Immunoperoxidase assays on autopsy tissue. Sections of epidermis 
(a and b) and pancreas (c and d) were stained as described in Materials and 
Methods.  (a)  Epidermis,  35/~Hll;  (b)  epidermis,  34/3E12;  (c)  pancreas, 
35/~Hll;  (d)  pancreas,  34/~E12;  (e)  Dermal  blood  vessel,  17,8G3. In  (c), 
35/3Hll  stains both the pancreatic duct  (an arrowhead marks the lumen of 
the duct),  and the surrounding acinar cells.  In  (d),  34/~E12 stains only the 
pancreatic ducts. The surrounding acinar cells are negative, x  200. 
TABLE  III 
Reactivity with Monoclonal Antibodies with Different 






tein  Keratin from stra- 
Vimen-  (Hepa-  tum corneum  Neuro- 
tin  (58  toma  filament 
kd)  cells)  66  57  51  49  GFAP  proteins 
17/3G3  +  -  +  +  +  +  + 
35/3Hll  -  + 
35/~D12  +  +*  +  +  +  +  + 
34/3E12  -  -  +  +  +  +  - 
* Only in A431. 
Summary of immunoblot results. 
reacts  with  the  high  molecular  weight  keratins  in  stratum 
corneum. Thus these antibodies are highly specific. The anti- 
vimentin antibody 17fiG3 crossreacts with GFAP and the high 
molecular weight keratins from stratum corneum. Hybridoma 
35flD12 is relatively nonspecific in that it binds to vimentin, 
GFAP,  the  54-kdalton protein of epithelial  cells,  and all the 
422  THE JOURNAL  OF  CELL  BIOLOGY  -  VOLUME  95,  1982 
proteins from stratum corneum. The different patterns of  cross- 
reactivity  suggest  that  vimentin,  the  54-kdalton  protein  of 
Hep3B and A431, GFAP, and multiple proteins in the keratin 
family share common epitopes. Hybridoma 35flD12 best illus- 
trates  this point because it recognizes all  of these molecules. 
The only filament proteins that do not react with these anti- 
bodies are the neurofilament peptides.  The lack of reactivity 
with the neurofilament peptides  is not due to the inability of 
the high molecular weight proteins to transfer onto nitrocellu- 
lose paper, because the 200-kdalton and  160-kdalton proteins 
are visible on amido black-stained strips of nitrocellulose, and 
monoclonal antibodies  made to the  200-kdalton protein  rec- 
ognize this protein on "western blots" (data not shown). It is 
likely  that  the  neurofilament  proteins  also  share  antigenic 
determinants with other intermediate filament proteins because 
a  monoclonal antibody generated against GFAP from spinal 
cord  recognizes all  the  other  intermediate  filament  peptides 
(19). 
One could argue that the intermediate  filament proteins of 
various molecular weights  identified  by these  antibodies  are 
not truly different,  but instead represent  different proteolytic 
fragments of the same molecule (31). This explanation is ruled 
out by the two-dimensional peptide maps that clearly demon- 
strate  that many of these molecules are unique proteins.  The vimentin map is distinct from that of the 58-kdalton protein 
from Hep3B,  the  54-kdalton epithelial  proteins,  and  the 66- 
kdalton keratin peptide. This latter molecule and the 54-kdal- 
ton epithelial proteins also differ. In addition, the 52-kdalton 
protein in the neurofdament preparation and fibroblast vimen- 
tin probably differ because a polyclonal anti-GFAP sera rec- 
ognizes this protein and not vimentin (data not shown). 
Antikeratin Antibody 34fl E12 
Hybridoma 34flE12, which recognizes proteins of 66 kdal- 
tons and 57  kdaltons in stratum corneum, yields unexpected 
results.  In immunofluorescence assays performed on a variety 
of tissue  culture  cell  lines,  the  antibody  decorates  only the 
intermediate  filaments  of epidermoid carcinoma cells.  When 
assayed on Carnoy's luted  tissue  from autopsy and  surgical 
specimens,  the antibody decorates squamous epithelium and 
some, but not all,  nonsquamous epithelium (Fig. 5 b  and d). 
For example, pancreatic duct epithelium reacts with 34flE12, 
but  pancreatic  acinar  cells  do  not.  Similarly,  the  antibody 
recognizes bile  ducts  in  liver  but  not  hepatocytes (data  not 
shown). In immunoblot experiments,  the antibody recognizes 
proteins  of 66  kdaltons  and  57  kdaltons  in  all  cells  tested, 
including cultured cells negative in immunofluorescence assays 
and  intact  tissue  negative  in  immunoperoxidase  assays.  A 
protein of 66 kdaltons is identified in immunoblots of spleen 
and lymph node, neither of which reacts with the antibody in 
immunoperoxidase  assays  (data  not  shown).  Therefore,  the 
antibody recognizes peptides of similar molecular weight in all 
ceils examined by "western blots" yet reacts only with specific 
tissues in immunofluorescence or immunoperoxidase assays. 
We do not understand the reason for this apparent discrep- 
ancy in reactivity. One could argue that the 66-kdalton proteins 
of positive  and  negative  cells  differ  such  that  the  antibody 
recognizes the native protein of only A431 cells, but recognizes 
the  SDS  denatured  proteins  of all ceils.  This  explanation  is 
unlikely because the peptide maps of the 66-kdalton proteins 
from A431  and Hep3B are identical (Fig. 4).  However, there 
still may be subtle sequence differences between the two mol- 
ecules  that  are  not demonstrated  by two-dimensional  maps. 
Another  explanation  is  that  the  66-kdalton  and  57-kdalton 
proteins are organized in filaments in only A431. These anti- 
gens may have a different intracellular location in the negative 
cells or may be localized in filaments such that the epitope is 
masked or blocked, thereby preventing antibody binding.  A 
third possibility is that the positive cells may contain more of 
these proteins than the negative cells.  However, we have not 
consistently seen quantitative differences between positive and 
negative cells.  Finally, it is possible that the "blot" procedure 
does  not  identify  the  correct  antigen,  but  instead  shows  a 
serendipitous reactivity with molecules unrelated  to interme- 
diate  filaments  in the  cell lysates.  Such a  phenomenon was 
observed with monoclonal antibodies to the Thy-l antigen that 
also  cross-react  with  vimentin  (32).  This  explanation  seems 
unlikely for the following reasons: (a) Pruss et al.  09) have 
described  a  monoclonal antibody capable  of recognizing all 
classes of intermediate filaments that also identifies a 66-kdal- 
ton  protein  in  many cells,  and  (b)  A  66-kdalton  peptide  is 
present  in cytoskeletal preparations  from all cells,  including 
those that do not react with 34flE12 (Fig.  1). 
The peptide map data also show that the 66-kdalton protein 
from stratum corneum is not identical to the 66-kdalton pro- 
teins of A431 or Hep3B (Fig. 4).  Therefore these three mole- 
cules must contain a  common epitope(s)  recognized by anti- 
body 34flE12. 
The S4-kdalton  Protein of Epithelial Cells In 
Vitro: Differentiation of "'Cytokeratins'"  and 
Keratins from Stratum Corneum 
Nonsquamous epithelial cells generally react with antibodies 
made against keratin from bovine hoof or human skin (5-8). 
The proteins that comprise the intermediate filaments of epi- 
thelial  cells  have  therefore  been  termed  "cytokeratins".  Hy- 
bridoma 35fill11 demonstrates that a "cytokeratin" from hep- 
atoma cells possesses a unique epitope not found in the family 
of keratins from stratum corneum. Similar observations have 
been made by Franke et al.  (5),  using polyclonal sera raised 
against bovine hoof keratin, and sera directed against individ- 
ual intermediate filament proteins from mouse liver. Addition- 
ally, Lane (33) has made monoclonal antibodies to cytokeratin 
that recognize 45-kdalton proteins in PtK1 cells and also stain 
nonsquamous epithelium. 
35fill I 1 identifies a 54-kdalton protein in many tissue culture 
epithelial  cell  lines  and  decorates  almost  all  nonsquamous 
epithelium in Carnoy's-fixed tissue (manuscript in preparation) 
but  does  not recognize proteins  from stratum  corneum and 
does not react with squamous epithelium (Fig. 5 a). Therefore, 
it appears that the 54-kdalton protein is a major component of 
the  intermediate  filaments  of nonsquamous epithelium,  and 
antibody 35flHll  can be used to distinguish  squamous from 
nonsquamous epithelium.  However, we cannot be certain of 
this latter statement because A431, a tissue culture line derived 
from a  squamous  carcinoma,  contains  a  54-kdalton  protein 
recognized by 35fill11.  It remains to be determined  whether 
the presence of the 54-kdalton protein in A431 is the result of 
tissue culture, or whether the 54-kdalton protein is present in 
squamous carcinomas and not in normal squamous epithelium. 
Peptides of Similar Molecular Weights in 
Different Cells 
Some cells contain intermediate filament proteins of similar 
molecular weight  that  can  be  distinguished  on  the  basis  of 
reactivity  with  the  different  monoclonal antibodies.  For ex- 
ample,  a  54-kdalton  peptide  is  present  in  both  Hep3B  and 
A43 I, but in immunoblot experiments antibody 35flD 12 reacts 
with only the molecule from A431 cells.  This result suggests 
that the epitope may be modified or that the arrangement or 
distribution of the epitope in these two molecules is different. 
Similarly,  antibody  17fiG3  does not  bind  to the  58-kdalton 
protein in Hep3B,  suggesting that this  protein  and vimentin 
from human fibroblasts are not identical.  The peptide  maps 
demonstrate  that  these  molecules  do  differ.  The  54-kdalton 
proteins of A431  and Hep3B are not identical,  and vimentin 
and the 58-kdalton protein of Hep3B are markedly different. 
These results show that much sequence heterogeneity may exist 
within a  specific class of intermediate  filament protein,  even 
among those of similar molecular weight. 
Clinical Application of these Antibodies 
One  objective  of this  project  was  to  generate  antibodies 
specific for different  cell types.  For tissue  culture  cells,  this 
seems to have been accomplished. Antibody 17fiG3 recognizes 
vimentin,  a  mesenchymal cell  marker  (20,  21).  Reaction  of 
17fiG3  with cultured epithelial ceils results from the presence 
of vimentin  in  these  cells  (data  not  shown)  (2).  Although 
capable of reacting with keratin in immunoblot experiments, 
the antibody does not recognize epidermoid  carcinoma cells 
(A431) and does not decorate epithelial ceils that normally do 
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antibody  35flHl 1 recognizes a  54-kdalton  protein present  in 
nonsquamous epithelial cells. The epithelial cells listed in Table 
II that do not react with this antibody (bladder, fetal intestine) 
do  not  contain  any  immunologicaUy  detectable  54-kdalton 
protein. This  antibody  also reacts with nonsquamous  epithe- 
lium in intact tissue (Fig. 5). The ant[keratin antibody 34BE 12 
recognizes squamous  epithelium and some, but not all, non- 
squamous epithelium. Antibodies 35BH 11 and 34/~E 12 identify 
two unique cytokeratin epitopes expressed in different epithe- 
lial cells and therefore may be useful in distinguishing different 
carcinomas (neoplasms of epithelial origin). We are beginning 
to  use  these  antibodies  clinically  to  determine  the  ceUular 
origin of poorly differentiated neoplasms. 
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